Loading...
OraSure Technologies, Inc.
OSUR•NASDAQ
Healthcare
Medical - Instruments & Supplies
$3.36
$0.04(1.20%)
OraSure Technologies, Inc. (OSUR) Financial Performance & Income Statement Overview
Review OraSure Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-54.17%
↓ 54.17%
Operating Income Growth
-186.43%
↓ 186.43%
Net Income Growth
-136.34%
↓ 136.34%
Operating Cash Flow Growth
-80.67%
↓ 80.67%
Operating Margin
-39.49%
↓ 39.49%
Gross Margin
72.48%
↑ 72.48%
Net Profit Margin
-34.37%
↓ 34.37%
ROE
-7.71%
↓ 7.71%
ROIC
-8.50%
↓ 8.50%
OraSure Technologies, Inc. (OSUR) Income Statement & Financial Overview
Review OraSure Technologies, Inc.'s (OSUR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $37.45M | $264000.00 | $54.34M | $54.13M |
| Cost of Revenue | $23.88M | -$16.81M | $28.76M | $29.84M |
| Gross Profit | $13.57M | $17.07M | $25.58M | $24.30M |
| Gross Profit Ratio | $0.36 | $64.66 | $0.47 | $0.45 |
| R&D Expenses | $6.09M | $5.62M | $6.12M | $7.65M |
| SG&A Expenses | $19.90M | $17.45M | $19.49M | $20.00M |
| Operating Expenses | $25.98M | $23.07M | $25.61M | $27.65M |
| Total Costs & Expenses | $49.86M | $6.26M | $54.37M | $57.48M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.50M | $0.00 | $2.61M | $2.73M |
| EBITDA | -$9.92M | -$6.00M | $826000.00 | -$1.02M |
| EBITDA Ratio | -$0.26 | -$22.72 | $0.02 | -$0.02 |
| Operating Income | -$12.42M | -$6.00M | -$34000.00 | -$3.35M |
| Operating Income Ratio | -$0.33 | -$22.72 | -$0.001 | -$0.06 |
| Other Income/Expenses (Net) | $2.91M | $2.78M | $3.07M | -$251000.00 |
| Income Before Tax | -$9.51M | -$3.22M | $326000.00 | -$3.60M |
| Income Before Tax Ratio | -$0.25 | -$12.19 | $0.006 | -$0.07 |
| Income Tax Expense | $758000.00 | $678000.00 | $381000.00 | -$18000.00 |
| Net Income | -$10.79M | -$4.51M | -$615000.00 | -$3.58M |
| Net Income Ratio | -$0.29 | -$17.07 | -$0.01 | -$0.07 |
| EPS | -$0.00 | -$0.06 | -$0.008 | -$0.05 |
| Diluted EPS | -$0.00 | -$0.06 | -$0.008 | -$0.05 |
| Weighted Avg Shares Outstanding | $74.60M | $74.58M | $74.16M | $73.95M |
| Weighted Avg Shares Outstanding (Diluted) | $74.60M | $74.58M | $74.16M | $73.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan